EUROMEDtAB
20t3
-POSTERS
M361cosT
EFFEcTlVE,
HlGH-THRoUGHPuTANALYS|s
oF
VlTAMlN D
uslNG
MİcRo-FLow
Lc-Ms/Ms
E. McClure, M. Jarvis
AB
SCIEX, Concord, ON, CanadaBackground:Micro-flow liquid chromatography has become a compelling alternative to conventional HPLC for many analyses given
its
cost-reduction and time-saving potential. Lower solvent consumption resulting from the use of micro-flow rates(5-60 pl/min), as compared to a typical flow rate of 500 pl/min using conventional HPLC, significantly reduces solvent and waste disposal
costs.
ln
addition, high on-column linear velocities and low mixing and delay volumes a|low for fast chromatography and thus higher sample throughput. Thesebenefits are realized while sensitivity is maintained or enhanced as compared to conventional HPLC, making micro-flow LC an exceilent fit for the analysis of Vitamin D given the sensitivity and throughput requirements of this assay.
Methods: Here we present the details of the analysis of 25-monohydroxy Vitamin D2 and 2S-monohydroxy Vitamin D3
using
the
Eksigent
ekspertTMmicrolC
200
system
incombination with the
AB SClEX
QTRAP@ 4500 LC/MS/MS system. Chromatographic separation of the two compounds is achieved using a Halo C18 column (0.5x50 mm,2.7 pm) and a water/methanol/formic acid gradient. Total runtime for the ana|ysis is 3 minutes, which is achieved at a flow rate of 20pl/min. To avoid introducing early-eluting matrix to the system,
the first part of the gradient is diveıled to waste thus improving robustness and column lifetime.
Results: The Limit of Quantitation (LOQ) for the analysis was determined using 'blank'stripped serum and spiked serum and found to be below 4 nglmL, and 5 ng/ml for 2S-monohydroxy Vitamin D3 and 2S-monohydroxy Vitamin D2, respectively, Accuracies were within 92-109o/o across the calibration range (1-"l00 ng/ml), with CVs below 15% based on n=5 for each calibration concentration. Serum samples from donors were also analyzed using the method described above, and the results indicate that method peı,formance is comparable to that
of a conventional HPLC method.
Conclusions: An LC-MS/MS method has been developed for the analysis of 25-hydroxyvitamin D2 and D3 in human serum
using
micro-flow,LC,
resultingin
a
reductionof
solvent consumption and faster analytical run-times.M362
EFFECTS
OF CURCUMlN SUPPLEMENTATION ONLıVER METABoLıSM
lN RATS FED A HIGH-FAT D|ETA
PROTEOMİC
APPROACH
H. Kocak(1), Y. Oner-lyidogan(2), A.T. Bayka|(3), M.
Seyidhanoglu(2), A. Cevik(a), F. Gurdol(2), M. Uys21(2)
1Biochemistry, Faculty of Medicine, Istanbul Bilim lJniversity, Esentepe. lstanbul. Turkey
'Biochemistry. lstanbul Faculty of Medicine, lstanbul University, Çapa, Turkey
" Genetic Engineering and Biotechnology lnstitute,
rÜ BİTeX-Uarmara Research Center, Kocaeli, Turkey aLaboratory Animal Biology and Applied Biomedical
Techniques, lnstitute for Experimental Research and Applied Medical Research, lstanbul University, Çapa,
Turkey
Background: ln the modern world, many individuals routinely consume diets rich in bnimal fat, leading to a high incidence of obesity. Curcumin (d iferuloylmethane, iu rmeric) extracted from
the dried root of the rhizome Curcuma longa, is a popularAsian
dietary
spice used in
curry. Curcuminis the
most active component of turmeric, comprising 2-8olo by weight. Proteomics is an important tool for elucidating the cellular response tovarious treatments including dietary factors.The aim of the study was to investigate the effect of curcumin treatment on
hepatic
proteome
in
rats
fed
high-fat
diet
(HFD). Methods: Male Sprague-Dawley rats were divided into six groups. Group ,1 was fed control diet ('10% of total calories fromfat). Groups
2and3
were given curcumin (100 and 400 mg/kgbw/day, respectively ) by gavage for B weeks and were fed control diet. Group 4 was fed HFD (60% of total calories from
fat). Groups 5 and 6 received HFD together with the two doses
of curcumin, respectively. ln order to understand the molecular changes
in
liver ceIls,we
performeda
nano LC-MS/MS analyses.Results: Our results identified 539 proteins and of these, differential expression of 122were calculated to be statistically significant (P <0,05). Proteomic analysis revealed '11 proteins
which
were
associatedwith lipid
metabolism. Curcumin treatment caused changes in the expressions of three hepatic proteins such as carnitine O palmitoyltransferase 1, ATP citrate synthase and acyl CoA binding protein in HFD fed rats. The results were confirmed by western blot.Conclusions: The most outstanding effects of the curcumin
treatment in HFD may be considered as the inhibition of hepatic lipid synthesis and the enhancement of fatty acid oxidation. Curcumin treatment
is
assumed
to
affect
liver
protein expressions. To the best of our knowiedge, this is the first study reflecting the beneficial effects of curcumin treatment in fattyliver metabolism by performing a proteomic